Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patients

R. P. Irwin, John Nutt, William Woodward, S. T. Gancher

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Blood pressure effects of i.v. levodopa were examined in parkinsonian patients with stable and fluctuating responses to levodopa. The magnitude of the hypotensive effect of levodopa was concentration dependent and was fit to an E(max) model in fluctuating responders. Stable responders demonstrated a small hypotensive response. Baseline blood pressures were higher in fluctuating patients; a higher baseline blood pressure correlated with greater hypotensive effects. Antiparkinsonian effects of levodopa temporally correlated with blood pressure changes. Phenylalanine, a large neutral amino acid (LNAA) competing with levodopa for transport across the blood-brain barrier, reduced the hypotensive and antiparkinsonian effects of levodopa. We conclude that levodopa has a central hypotensive action that parallels the motor effects in fluctuating patients. The hypotensive effect appears to be related to the higher baseline blood pressure we observed in fluctuating patients relative to stable patients.

Original languageEnglish (US)
Pages (from-to)365-374
Number of pages10
JournalClinical Neuropharmacology
Volume15
Issue number5
StatePublished - 1992
Externally publishedYes

Fingerprint

Levodopa
Antiparkinson Agents
Hypertension
Blood Pressure
Neutral Amino Acids
Blood-Brain Barrier
Phenylalanine

Keywords

  • Amino acid transport
  • Blood pressure
  • Blood- brain barrier
  • Levodopa
  • Parkinson disease
  • Pharmacodynamics

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patients. / Irwin, R. P.; Nutt, John; Woodward, William; Gancher, S. T.

In: Clinical Neuropharmacology, Vol. 15, No. 5, 1992, p. 365-374.

Research output: Contribution to journalArticle

@article{51d6ed113f7f4520b947b1ba52e18f3e,
title = "Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patients",
abstract = "Blood pressure effects of i.v. levodopa were examined in parkinsonian patients with stable and fluctuating responses to levodopa. The magnitude of the hypotensive effect of levodopa was concentration dependent and was fit to an E(max) model in fluctuating responders. Stable responders demonstrated a small hypotensive response. Baseline blood pressures were higher in fluctuating patients; a higher baseline blood pressure correlated with greater hypotensive effects. Antiparkinsonian effects of levodopa temporally correlated with blood pressure changes. Phenylalanine, a large neutral amino acid (LNAA) competing with levodopa for transport across the blood-brain barrier, reduced the hypotensive and antiparkinsonian effects of levodopa. We conclude that levodopa has a central hypotensive action that parallels the motor effects in fluctuating patients. The hypotensive effect appears to be related to the higher baseline blood pressure we observed in fluctuating patients relative to stable patients.",
keywords = "Amino acid transport, Blood pressure, Blood- brain barrier, Levodopa, Parkinson disease, Pharmacodynamics",
author = "Irwin, {R. P.} and John Nutt and William Woodward and Gancher, {S. T.}",
year = "1992",
language = "English (US)",
volume = "15",
pages = "365--374",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patients

AU - Irwin, R. P.

AU - Nutt, John

AU - Woodward, William

AU - Gancher, S. T.

PY - 1992

Y1 - 1992

N2 - Blood pressure effects of i.v. levodopa were examined in parkinsonian patients with stable and fluctuating responses to levodopa. The magnitude of the hypotensive effect of levodopa was concentration dependent and was fit to an E(max) model in fluctuating responders. Stable responders demonstrated a small hypotensive response. Baseline blood pressures were higher in fluctuating patients; a higher baseline blood pressure correlated with greater hypotensive effects. Antiparkinsonian effects of levodopa temporally correlated with blood pressure changes. Phenylalanine, a large neutral amino acid (LNAA) competing with levodopa for transport across the blood-brain barrier, reduced the hypotensive and antiparkinsonian effects of levodopa. We conclude that levodopa has a central hypotensive action that parallels the motor effects in fluctuating patients. The hypotensive effect appears to be related to the higher baseline blood pressure we observed in fluctuating patients relative to stable patients.

AB - Blood pressure effects of i.v. levodopa were examined in parkinsonian patients with stable and fluctuating responses to levodopa. The magnitude of the hypotensive effect of levodopa was concentration dependent and was fit to an E(max) model in fluctuating responders. Stable responders demonstrated a small hypotensive response. Baseline blood pressures were higher in fluctuating patients; a higher baseline blood pressure correlated with greater hypotensive effects. Antiparkinsonian effects of levodopa temporally correlated with blood pressure changes. Phenylalanine, a large neutral amino acid (LNAA) competing with levodopa for transport across the blood-brain barrier, reduced the hypotensive and antiparkinsonian effects of levodopa. We conclude that levodopa has a central hypotensive action that parallels the motor effects in fluctuating patients. The hypotensive effect appears to be related to the higher baseline blood pressure we observed in fluctuating patients relative to stable patients.

KW - Amino acid transport

KW - Blood pressure

KW - Blood- brain barrier

KW - Levodopa

KW - Parkinson disease

KW - Pharmacodynamics

UR - http://www.scopus.com/inward/record.url?scp=0026705584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026705584&partnerID=8YFLogxK

M3 - Article

C2 - 1423336

AN - SCOPUS:0026705584

VL - 15

SP - 365

EP - 374

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 5

ER -